Global insulin pump market is anticipated to grow at a CAGR of 8.5% during the forecast period (2024–2031). The market growth is driven by the increasing incidence of diabetes due to aging, obesity, and an unhealthy lifestyle. Additionally, the rising R&D and the increasing integration of IT in the healthcare industry are driving market growth. However, the high cost of insulin pumps and the associated skin infection are impeding the market growth. In addition, a lack of skilled professionals- capable of efficiently managing insulin pumps is limiting the market growth. Moreover, ongoing research into aerosolized insulin for inhalation, and insulin-producing stem cell implants shows promising results, which could present a convenient substitution to the insulin pump technology and threaten the market growth.
Browse the full report description of “Insulin Pump Market Size, Share & Trends Analysis Report by Type (Traditional Pumps, Disposable Pumps, Smart Pumps), and by End-User (Hospitals & Clinics, and Homecare) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/insulin-pump-market
Recent Developments
Market Coverage
· The market number available for 2023-2031
· Base year: 2023
· Forecast period: 2024-2031
· Segment Covered-
o By Type
o By End-Users
· Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape: B. Braun Melsungen AG, Insulet Corp. (Omnipod), Medtronic Plc, Tandem Diabetes Care, Inc., and Sanofi SA among others.
Key questions addressed by the report
Global Insulin Pump Market Report Segment
By Type
By Channel
Global Insulin Pump Market Report Segment by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Italy
· Spain
· France
· Rest of Europe
Asia-Pacific
· China
· India
· Japan
· South Korea
· Rest of Asia-Pacific
Rest of the World
· Latin America
· Middle East and Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/insulin-pump-market